About Cosmo Bio
Cosmo Bio is a publicly listed company based in Koto (Japan) founded in 1983. Provider of drug research and sales marketing services for life science companies. Its chief executive, as recorded, is Haruhisa Sakurai. Its website cosmobio.co.jp draws about 131 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services.
Company details
Cosmo Bio was established in 1983 in Koto City, Japan. Operations are centered on the life sciences sector, where drug research services are offered alongside sales and marketing support for related companies. The firm is led by CEO Haruhisa Sakurai. Focus remains on facilitating research and commercial activities within the Japanese market and beyond.
- Headquarters Koto, Japan
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cosmobio.co.jp
- Social X YouTube
- Legal Name Cosmo Bio Co., Ltd.
- Annual Revenue$68.74 M (USD)7.26as on Dec 31, 2025
- Net Profit$2.14 M (USD)28.24as on Dec 31, 2025
- EBITDA$3.25 M (USD)11.87as on Dec 31, 2025
Apps and channels of Cosmo Bio
its YouTube channel コスモ・バイオ has 20 subscribers and 30 videos.
Videos from Cosmo Bio
The most watched videos on Cosmo Bio's YouTube channel, コスモ・バイオ (20 subscribers). Click a video to play it here.
More on コスモ・バイオ.
People of Cosmo Bio
1 people are tracked at Cosmo Bio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Haruhisa Sakurai | CEO | Leadership |
Complete people profiles for Cosmo Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cosmo Bio
Cosmo Bio is a publicly listed company on the TSE with ticker symbol 3386 in Japan, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Jul 2013
- Listed onTSE: 33860
- Listed entityCosmo Bio Co., Ltd.
- Exchange sectorDistribution services
- ISINJP3298700000
- Share price1,235.00 JPY (-0.72% on the day) · 2026-10-14
- Market capitalisation7,205,068,630.00 JPY
- Price to earnings19.2
- EPS (diluted, trailing year)64.17 JPY
- Dividend yield4.02%
- Volume (last session)2,100
Financials of Cosmo Bio
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 10.77B JPY | 336.0M JPY | 509.0M JPY |
| 2024 | 10.04B JPY | 262.0M JPY | 455.0M JPY |
| 2023 | 9.34B JPY | 442.0M JPY | 669.0M JPY |
| 2022 | 9.55B JPY | 517.0M JPY | 958.0M JPY |
| 2021 | 9.23B JPY | 737.0M JPY | 1.22B JPY |
Detailed financial statements for Cosmo Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Cosmo Bio
The website of Cosmo Bio (cosmobio.co.jp) receives about 130.8K visits a month.
- Monthly visits130.8K
▲ 10.3% vs previous month
Websites whose visitors overlap most with Cosmo Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
abcam.co.jp | abcam.co.jp | 100% | #535,413 | – | |
ptglab.co.jp | ptglab.co.jp | 95% | #676,043 | – | |
dojindo.co.jp | dojindo.co.jp | 90% | #381,122 | – | |
cellsignal.jp | cellsignal.jp | 89% | #611,480 | – | |
wakenyaku.co.jp | wakenyaku.co.jp | 81% | #545,917 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Cosmo Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cosmo Bio
Complete news archive for Cosmo Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cosmo Bio
Cosmo Bio was founded in 1983.
Cosmo Bio is headquartered in Koto, Japan. It is registered at Koto, Tokyo, Japan.
Haruhisa Sakurai is the CEO of Cosmo Bio, as recorded in our data.
Annual revenue of Cosmo Bio is $68.74M as on Dec 31, 2025.
Cosmo Bio was established in 1983 in Koto City, Japan. Operations are centered on the life sciences sector, where drug research services are offered alongside sales and marketing support for related companies. The firm is led by CEO Haruhisa Sakurai. Focus remains on facilitating research and commercial activities within the Japanese market and beyond.
Yes, Cosmo Bio is publicly traded on TSE under the ticker symbol 3386.
The website of Cosmo Bio receives about 131 thousand visits a month.